
CRYO-CELL INTL INC
CCELNYSE AMERICANTrading Snapshot
- Day Range
- $3.50 β $3.57
- 52-Week Range
- $2.72 β $5.01
- Volume
- $2.40B
- Avg Volume
- $3.12B
- Shares Outstanding
- 8.1M
- Next Earnings
- Oct 23, 2026
Fundamentals Snapshot
- Annual Revenue
- $32M
- Last Q Revenue
- $8M
- P/E Ratio
- -11.9
- P/S Ratio
- 0.9x
- EPS (TTM)
- $-0.31
- Dividend Yield
- 0.00%
Why Investors Own CCEL
- βHigh-growth profile β revenue up +35.2% YoY with expanding US Equity exposure.
- βHealthy economics β 72% gross margin and 10% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About CRYO-CELL INTL INC
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
CRYO-CELL INTL INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift CCEL price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
CRYO-CELL INTL INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.